• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Quit calling me Shirley









thanks Mike. But even you don’t have the superpowers to pull the train out of the pile of rubble at the bottom of the cliff where it derailed with Anderson as the engineer.

It’s over, get a shovel and just bury it.